Prana PBT2 IIa Trial

Prana PBT2 IIa Trial: "Thursday, Prana Biotechnology Limited (PRAN | charts | news | PowerRating), revealed the grant of approval from regulatory authority of Sweden, Medical Products Agency to initiate PhaseIIa clinical trial for its drug, PBT2, indicated in the treatment of Alzheimer's disease in Sweden. The company said the trial would be conducted at seven locations and expects results of the trial during the fourth quarter of 2007."